To assess this question, we treated CD37KO and WT lymphoma cells with specific inhibitors for FATP1, arylpiperazine 5k (DS22420314, referred to as compound ”5k” and “12a”)43,44. This evidence concerns the gene SLC27A1 and lymphoma.